BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2072747)

  • 21. [Combination therapy of chronic myelogenous leukemia with busulfan and bestatin].
    Uzuka Y; Saito Y
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):571-8. PubMed ID: 2012399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
    Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
    Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breakpoint cluster region (BCR) gene rearrangement studies in chronic myeloid and acute lymphoblastic leukemias.
    Chin YM; Bosco JJ; Koh CL
    Med J Malaysia; 1992 Jun; 47(2):110-3. PubMed ID: 1494330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Philadelphia chromosome positive acute mixed lineage leukemia with bcr (M-BCR-1) rearrangement].
    Okada S; Shimizu T; Harada H; Miyoshi Y; Takizawa Y; Hagiwara S; Mori H; Niikura H; Terada H; Fujita K
    Rinsho Ketsueki; 1990 Jan; 31(1):89-94. PubMed ID: 2156095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission.
    Potenza L; Luppi M; Riva G; Marasca R; Martinelli S; Torelli G
    Haematologica; 2005 Sep; 90(9):1275-7. PubMed ID: 16154854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia.
    Pane F; Cimino G; Izzo B; Camera A; Vitale A; Quintarelli C; Picardi M; Specchia G; Mancini M; Cuneo A; Mecucci C; Martinelli G; Saglio G; Rotoli B; Mandelli F; Salvatore F; Foà R;
    Leukemia; 2005 Apr; 19(4):628-35. PubMed ID: 15744351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Philadelphia-chromosome-positive acute leukemia by clinical, immunocytochemical, and gene analysis.
    Tien HF; Wang CH; Chuang SM; Lee FY; Liu MC; Chen YC; Shen MC; Lin DT; Lin KH; Lin KS
    Leukemia; 1992 Sep; 6(9):907-14. PubMed ID: 1325582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Disappearance of Philadelphia chromosomes after remission induction in lymphoid crisis of chronic myelogenous leukemia].
    Nagafuji K; Iwakiri R; Miyamoto T; Okamura H; Yokota E; Matsumoto I
    Rinsho Ketsueki; 1992 Sep; 33(9):1226-30. PubMed ID: 1433945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and characterization of "biphenotypic" acute leukemia cell lines with a variant Ph translocation t(9;22;10) (q34;q11;q22).
    Ariyasu T; Matsuo Y; Harashima A; Nakamura S; Takaba S; Tsubota T; Orita K
    Hum Cell; 1998 Mar; 11(1):43-50. PubMed ID: 9710720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ph1-positive leukemia: cytogenetic outline and prognosis].
    Misawa S
    Nihon Rinsho; 1992 Jun; 50(6):1274-80. PubMed ID: 1518145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
    Arana-Trejo RM; Ovilla-Martínez R; Gómez-Morales E; Meillon-García L; Cervantes-Peredo A; González-Llaven J; Pizzuto-Chávez J; Kofman-Alfaro S
    Rev Invest Clin; 1997; 49(3):209-14. PubMed ID: 9380976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
    Merx K; Müller MC; Kreil S; Lahaye T; Paschka P; Schoch C; Weisser A; Kuhn C; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
    Leukemia; 2002 Sep; 16(9):1579-83. PubMed ID: 12200666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon.
    Lion T; Gaiger A; Henn T; Hörth E; Haas OA; Geissler K; Gadner H
    Leukemia; 1995 Aug; 9(8):1353-60. PubMed ID: 7643624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
    Ko BS; Tang JL; Lee FY; Liu MC; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF
    Am J Hematol; 2002 Dec; 71(4):291-9. PubMed ID: 12447959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunogenotypic and clonal culture studies in Philadelphia chromosome-positive acute leukemia].
    Ohyashiki JH; Tauchi T; Ohyashiki K; Toyama K; Miyauchi J
    Rinsho Ketsueki; 1991 Apr; 32(4):333-7. PubMed ID: 2067075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies.
    Talpaz M; Estrov Z; Kantarjian H; Ku S; Foteh A; Kurzrock R
    J Clin Invest; 1994 Oct; 94(4):1383-9. PubMed ID: 7929813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A patient with clinically de novo Ph-positive acute lymphoblastic leukemia had Ph chromosome in all metaphases at the time of hematological remission].
    Fujiwara M; Soga N; Kurokawa I
    Rinsho Ketsueki; 1996 Sep; 37(9):833-7. PubMed ID: 8914471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletions on der(9) chromosome in adult Ph-positive acute lymphoblastic leukemia occur with a frequency similar to that observed in chronic myeloid leukemia.
    Specchia G; Albano F; Anelli L; Storlazzi CT; Zagaria A; Mancini M; Cuneo A; Pane F; Foà R; Manolelli F; Liso V; Rocchi M
    Leukemia; 2003 Mar; 17(3):528-31. PubMed ID: 12646940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
    Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Qiu JY; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.